| Name | Title | Contact Details |
|---|
Corindus Vascular Robotics, Inc. is a global technology leader in robotic-assisted vascular interventions. The company`s CorPath® System is the first FDA-cleared medical device to bring robotic-assisted precision to radial, coronary and peripheral procedures. During the procedure, the interventional cardiologist sits at a radiation-shielded workstation to advance stents and guidewires with millimeter-by-millimeter precision. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries. With the CorPath System, Corindus Vascular Robotics brings robotic precision to radial and complex interventional procedures to help optimize clinical outcomes and minimize the costs associated with complications of improper stent placement with manual procedures. Corindus stands behind its product with its unique $1,000 hospital credit "One Stent Program."
Physio-Control, now part of Stryker, is the world leader in the development, manufacture, sale and service of external defibrillator/monitors and emergency medical response products and services. We envision a world in which no person dies suddenly as a result of an acute, treatable medical event. Physio-Control Team Members are part of a unique group who love what they do - and why they do it. Our Team is comprised of talented individuals who have purpose, creativity and passion, and we are proud to be leading the industry dedicated to saving and extending lives around the globe. Our Team Members are our most valuable asset and what sets us apart from our competitors. We are committed to our mission to save lives through hard work and dedication.
Gillette Canada Company is a Belmont, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Valleylab is a Boulder, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Microbot Medical was founded with the vision of pioneering Micro Invasive Surgery, transforming one of the biggest trends in healthcare - Minimally Invasive Surgery (estimated to be close to $20B by 2015); the company will provide transformational micro invasive technologies with the accuracy of robots and automated instruments to assist physicians in targeting the disease site with exquisite precision. Microbot will solve one of the largest unmet needs in the medical field, where morbidity as a result of surgery is more frequently due to trauma involved in gaining access to the area to perform the intended procedure rather than from the procedure itself. Through its unique platforms, Microbot will reach multiple surgical spaces, capitalizing on the fact that minimally invasive techniques have been applied to most of the surgical specialties. Microbot`s ViRob platform is an Autonomous Advancing Micro Robot (AAMR), less then 1mm in diameter, which has the ability to advance (forward/backward) within cavities/lumens (such as the typical human body`s veins and arteries). The TipCat platform is a self-propelled, flexible, see & treats endoscope/catheter. It is comprised of a series of interconnected balloons that provide forward and backward motion while allowing for a working channel to be available during the procedure. In developing its platforms, the company is focusing on multi-disciplinary platform of products.